| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 11,213 | $260.65 | $2,922,651.63 | -22.7% | -25.5% | +5.3% | |
| Jul 27, 2023 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 944 | $130.00 | $122,720.00 | -0.4% | -18.4% | +8.4% | |
| Jul 27, 2023 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 2,000 | $97.42 | $194,840.00 | -3.7% | -36.4% | -53.4% | |
| Jul 27, 2023 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 21,850 | $254.39 | $5,558,421.50 | -59.5% | +3.9% | +53.3% | |
| Jul 26, 2023 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 22,439 | $263.42 | $5,910,832.01 | -20.2% | -25.7% | +2.0% | |
| Jul 26, 2023 | DHR Danaher Corp /de/ | List Teri55 | Director | Sell | 3,490 | $263.30 | $918,917.00 | -16.6% | -25.7% | +2.0% | |
| Jul 26, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 61 | $7.41 | $452.01 | -1.3% | -56.5% | +345.8% | |
| Jul 25, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,347 | $46.58 | $109,323.26 | -3.5% | -14.9% | +125.3% | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Parnell Winfred | Director | Buy | 6,281 | $3.98 | $24,998.38 | +24.9% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Vos Ellen O'Connor | Director | Buy | 3,769 | $3.98 | $15,000.62 | +12.9% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Jordan Veronica Gh | Director | Buy | 3,769 | $3.98 | $15,000.62 | +12.2% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Sandford Nicole | President &CEO | Buy | 12,563 | $3.98 | $50,000.74 | +10.3% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Phan Ryan Thinh | CSO &COO | Buy | 628 | $3.98 | $2,499.44 | +19.0% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Merchant Minh Hoang | General Counsel And Secretary | Buy | 754 | $3.98 | $3,000.92 | +18.4% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Schuler Jack W45 | - | Buy | 181,800 | $2.75 | $499,950.00 | +10.7% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Herchuk Jannie Prestridge | Director | Buy | 8,794 | $3.98 | $35,000.12 | +58.5% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Fralick Celeste Rachelle | Director | Buy | 754 | $3.98 | $3,000.92 | +6.7% | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Hombeck Torsten | Chief Financial Officer | Buy | 754 | $3.98 | $3,000.92 | New | - | - | |
| Jul 24, 2023 | AWHL Aspira Women's Health Inc. | Cavanaugh Stefanie L. | Director | Buy | 6,281 | $3.98 | $24,998.38 | +21.9% | - | - | |
| Jul 24, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,570 | $47.83 | $75,086.66 | -2.3% | -14.3% | +127.7% | |
| Jul 24, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,578 | $47.83 | $123,295.94 | -1.2% | -14.3% | +127.7% | |
| Jul 24, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,333 | $47.58 | $63,423.97 | -0.1% | -14.3% | +127.7% | |
| Jul 24, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 800 | $47.83 | $38,260.72 | -0.4% | -14.3% | +127.7% | |
| Jul 20, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 163 | $7.85 | $1,279.55 | -1.3% | -54.1% | +318.8% | |
| Jul 19, 2023 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 1,300 | $100.00 | $130,000.00 | -17.9% | -30.5% | -51.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.